Medical science and research has helped move many parts of cardiology from potentially fatal conditions to more chronic issues for patients and doctors to address. Cholesterol control is moving in that direction thanks to new advancements in medication and surgical options.
Joon Sup Lee, MD (pictured), co-director of the UPMC Heart and Vascular Institute, chief, Division of Cardiology at the University of Pittsburgh School of Medicine (UPMC), associate professor in the Department of Medicine at the University of Pittsburgh, and an affiliated faculty member of the
McGowan Institute for Regenerative Medicine
, discussed some of the highlights from this year's meeting of the American College of Cardiology which was held in Chicago.
Located between the Cleveland Clinic and Philadelphia, Dr. Lee said the community-based approach UPMC takes to patient care is a small sampling of what life in the country is like as a whole and can help improve patient care elsewhere. Watch Dr. Lee’s video here as he answers these important questions:
- What are the biggest challenges in your field?
- What are your highlights from American College of Cardiology 2016?
- What can attendees take back to practice from this conference?
- What is the role of general cardiology?
- Are there certain areas that have seen more progress than others?
- What do you look to learn from the Hope3 Trial?
- How does your location affect your role in the field overall?
- What can patients do to improve their cardiovascular health?
- What is the future of this field?
Illustration: University of Pittsburgh Medical Center.
American College of Cardiology 2016
Clinical Trials.gov: Heart Outcomes Prevention Evaluation-3 (HOPE-3)
Bio: Dr. Joon Sup Lee